Physician profile
Stephanie Dewitt
NPI 1063791689
$483.13
in general payments reported to CMS, 2019-2025
18 companies · $15.63 in 2025
The $15.63 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $106 · 2022: $53.37 · 2023: $75.57 · 2024: $47.52 · 2025: $15.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $138.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $71.68 | 2019-2020 | |
| Angiodynamics, INC. | $64.00 | 2019 | |
| Conmed Corporation | $59.98 | 2023-2025 | Airseal, Conmed Specimen Retrieval |
| Hologic INC | $32.45 | 2022 | |
| Organogenesis INC. | $26.75 | 2024 | |
| Medtronic USA, INC. | $25.64 | 2019 | |
| Melinta Therapeutics, LLC | $24.59 | 2019-2020 | |
| Innocoll Pharmaceuticals Limited | $20.92 | 2022 | |
| Davol INC. | $20.77 | 2024 | Phasix Mesh |
| Checkpoint Surgical, INC | $19.62 | 2020 | |
| Sanara Medtech INC. | $17.67 | 2020 | |
| Baxter Healthcare | $16.81 | 2023 | Tisseel |
| Genzyme Corporation | $15.73 | 2019 | |
| Boston Scientific Corporation | $14.41 | 2023 | Exalt Model D |
| Takeda Pharmaceuticals U.S.A., INC. | $13.68 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $13.57 | 2019 | |
| Teleflex LLC | $12.45 | 2019 | |
| Bioptics, INC. | $12.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Dewitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.